Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,540 | 103 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $299.78 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $212.11 | 15 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $156.52 | 12 | $0 (2019) |
| Novo Nordisk Inc | $140.42 | 9 | $0 (2024) |
| Lilly USA, LLC | $140.14 | 8 | $0 (2024) |
| Amgen Inc. | $101.06 | 6 | $0 (2020) |
| Astellas Pharma US Inc | $92.55 | 4 | $0 (2024) |
| Exact Sciences Corporation | $86.09 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $59.66 | 3 | $0 (2024) |
| Shire North American Group Inc | $42.46 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.67 | 17 | AstraZeneca Pharmaceuticals LP ($93.34) |
| 2023 | $171.71 | 11 | AstraZeneca Pharmaceuticals LP ($55.77) |
| 2022 | $73.61 | 4 | PFIZER INC. ($36.16) |
| 2020 | $58.64 | 4 | Amgen Inc. ($18.06) |
| 2019 | $177.93 | 11 | PFIZER INC. ($45.86) |
| 2018 | $249.17 | 23 | PFIZER INC. ($127.06) |
| 2017 | $497.79 | 33 | Novo Nordisk Inc ($88.02) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.70 | General |
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Biological | ||||||
| 09/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Oncology | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: VACCINES | ||||||
| 07/08/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Respiratory | ||||||
| 05/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Diabetes | ||||||
| 03/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: VACCINES | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Oncology | ||||||
| 10/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Diabetes | ||||||
| 09/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2023 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: VACCINES | ||||||
| 04/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 584 | 723 | $165,450 | $61,908 |
| 2022 | 9 | 462 | 547 | $133,496 | $49,292 |
| 2021 | 11 | 437 | 531 | $104,804 | $43,906 |
| 2020 | 8 | 210 | 259 | $46,088 | $19,266 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 153 | 221 | $85,295 | $29,330 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 120 | 120 | $33,600 | $16,057 | 47.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 80 | $22,000 | $5,463 | 24.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 58 | 59 | $9,645 | $4,224 | 43.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $6,435 | $3,112 | 48.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 64 | $4,010 | $2,051 | 51.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 101 | 157 | $3,925 | $1,319 | 33.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $540.00 | $352.55 | 65.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 96 | 136 | $51,500 | $17,796 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 100 | 100 | $27,816 | $13,794 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 125 | $36,735 | $10,134 | 27.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 36 | 37 | $5,978 | $2,529 | 42.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $4,253 | $2,119 | 49.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 41 | $1,640 | $1,289 | 78.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $2,595 | $844.98 | 32.6% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 14 | 14 | $1,484 | $580.86 | 39.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 56 | 69 | $1,495 | $204.21 | 13.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 94 | 94 | $21,996 | $13,129 | 59.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 139 | $35,695 | $11,827 | 33.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 55 | 79 | $24,490 | $9,968 | 40.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 39 | 40 | $3,760 | $2,606 | 69.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,745 | $1,934 | 28.7% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 27 | 27 | $2,862 | $1,110 | 38.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,820 | $961.79 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 16 | $2,615 | $949.60 | 36.3% |
About Dr. Meredith Ray, MD
Dr. Meredith Ray, MD is a Family Medicine healthcare provider based in Feasterville Trevose, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497723944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Meredith Ray, MD has received a total of $1,540 in payments from pharmaceutical and medical device companies, with $310.67 received in 2024. These payments were reported across 103 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,540).
As a Medicare-enrolled provider, Ray has provided services to 1,693 Medicare beneficiaries, totaling 2,060 services with total Medicare billing of $174,372. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Feasterville Trevose, PA
- Active Since 03/10/2006
- Last Updated 05/20/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497723944
Products in Payments
- FARXIGA (Drug) $147.54
- CHANTIX (Drug) $132.59
- JANUVIA (Drug) $101.09
- Cologuard Collection Kit (Device) $86.09
- PREVNAR 20 (Biological) $69.44
- Myrbetriq (Drug) $68.14
- JARDIANCE (Drug) $63.88
- Victoza (Drug) $57.32
- ASMANEX (Drug) $55.43
- MOUNJARO (Drug) $44.36
- Aimovig (Biological) $43.24
- TRUMENBA (Biological) $42.74
- AIRSUPRA (Drug) $41.02
- TRULICITY (Drug) $40.79
- Prolia (Biological) $39.76
- SHINGRIX (Biological) $38.92
- Xhance (Drug) $26.94
- Veozah (Drug) $24.41
- VYVANSE (Drug) $23.05
- LYRICA (Drug) $22.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Feasterville Trevose
John Mcdonald, D.o, D.O
Family Medicine — Payments: $9,701
Dr. Si Lam, Do, DO
Family Medicine — Payments: $4,395
Alberto Larrieu, Md, MD
Family Medicine — Payments: $3,114
Sean Duffy, Do, DO
Family Medicine — Payments: $2,905
Dr. Gilbert Kasirsky, D.o, D.O
Family Medicine — Payments: $2,513
Douglas Kimmel, D.o, D.O
Family Medicine — Payments: $1,058